Floatz logo

Levoleucovorin

Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer

Taiho Oncology, Inc.Phase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

9 Active assets in the Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Taiho Oncology, Inc.
Phase 2CCC
Epirubicin
Taiho Oncology, Inc.
Phase 2CCC
Eloxatin
Taiho Oncology, Inc.
Phase 2CCC
Irinotecan
Taiho Oncology, Inc.
Phase 2CCC
CIS-DIAMMINEDICHLOROPLATINUM II
Taiho Oncology, Inc.
Phase 2CCC

View all 9 →

Same molecule, other indications

Levoleucovorin is also rated in:

gastroesophageal junction adenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
Advanced/Metastatic Gastroesophageal AdenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →